The Venture Codex Logo

The Venture Codex

CS Venture Opportunities Fund

Darien, CT, United States

Overview

Venture capital fund investing in advanced technology and life sciences.

Founded

2022

Deals · 12mo

0

Stage focus

Seed

Geographic focus

United States

Sector focus

—

Investment portfolio

2rounds
NAMEDATESIZE
Flashpoint Therapeutics
Oct 2023Participated
$10 MSeed
PteroDynamics
Feb 2023Led
$8 MSeed
Flashpoint Therapeutics
Oct 2023Participated
$10 MSeed
PteroDynamics
Feb 2023Led
$8 MSeed
2
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

CS Venture Opportunities Fund: 2 funding rounds are recorded in the selected participation categories.All available history.
CS Venture Opportunities Fund: 2 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Seed11

Monthly Deal Activity

CS Venture Opportunities Fund: 2 deals are recorded across 45 months.All available history.
CS Venture Opportunities Fund: 2 deals are recorded across 45 months. All available history
MonthDeals
Feb '231
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '231
Nov '230
Dec '230
Jan '240
Feb '240
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '240
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '250
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

CS Venture Opportunities Fund: Manufacturing is the largest displayed sector by deal count (1 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

CS Venture Opportunities Fund: Manufacturing is the largest displayed sector by deal count (1 deals). All available history
SectorDeals
Manufacturing1
Health & Life Sciences1
Space & Frontier Tech1

Deal Size Distribution

CS Venture Opportunities Fund: 2 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

CS Venture Opportunities Fund: 2 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M1
$10M-$25M1
$25M-$50M0
$50M-$100M0
$100M-$250M0
$250M-$500M0
$500M-$1B0
$1B+0

Deals By Geography

CS Venture Opportunities Fund: United States has the largest recorded deal count among the displayed regions (2 deals).All available history.

Top 1 of 1 regions; European countries are grouped as Europe.

CS Venture Opportunities Fund: United States has the largest recorded deal count among the displayed regions (2 deals). All available history
RegionDeals
United States2
CS Venture Opportunities Fund: 3 co-investors are shown, with Beta Lab sharing 1 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

CS Venture Opportunities Fund: 3 co-investors are shown, with Beta Lab sharing 1 recorded deals. All available history
Co-investorShared deals
Beta Lab1
Kairos Ventures1
Lavrock Ventures1

Investment Strategy

CS Venture Opportunities Fund: Led accounts for 50% and participating for 50% of round participation.All available history.
CS Venture Opportunities Fund: Led accounts for 50% and participating for 50% of round participation. All available history
CategoryDeals (count)Share (%)
Led150%
Participating150%
CS Venture Opportunities Fund: Single-lead accounts for 0% and co-led for 100% of lead dynamics.All available history.
CS Venture Opportunities Fund: Single-lead accounts for 0% and co-led for 100% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead00%
Co-led1100%

Team

No team members found for this fund.